Literature DB >> 549189

Partial purification and characterization of a cytotoxin from Clostridium difficile.

N S Taylor, J G Bartlett.   

Abstract

A trypsin-sensitive, heat-labile cytotoxin was purified from the supernatant of a culture of Clostridium difficile by a procedure that included ultrafiltration, precipitation with (NH4)2SO4, gel filtration, and ion-exchange chromatography. The procedure resulted in recovery of 20% of the cytotoxin and an estimated 1,500-fold increase in cytotoxic activity. The minimal amount of protein required to give an actinomorphic response in WI-38 cell cultures was 1.4 ng/ml. The estimated molecular weight of the cytotoxin is 240,000. A cytotoxin having similar properties was purified from the stool of a patient with antibiotic-associated pseudomembranous colitis by (NH4)2SO4 precipitation and gel filtration chromatography. This procedure resulted in a recovery of 26% of the cytotoxin, a 50-fold increase in cytotoxic activity, and a cytotoxic response with a minimum of 12.1 ng of protein/ml.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 549189     DOI: 10.1093/clinids/1.2.379

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  19 in total

Review 1.  Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.199

2.  Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin.

Authors:  I Florin; M Thelestam
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

3.  Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis.

Authors:  S W Rothman
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

4.  Enzyme immunoassay for detection of antibody to toxins A and B of Clostridium difficile.

Authors:  R P Viscidi; R H Yolken; B E Laughon; J G Bartlett
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

5.  Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters.

Authors:  J M Libby; B S Jortner; T D Wilkins
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

6.  Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.

Authors:  Simon A Hirota; Vadim Iablokov; Sarah E Tulk; L Patrick Schenck; Helen Becker; Jimmie Nguyen; Samir Al Bashir; Tanis C Dingle; Austin Laing; Jianrui Liu; Yan Li; Jeff Bolstad; George L Mulvey; Glen D Armstrong; Wallace K MacNaughton; Daniel A Muruve; Justin A MacDonald; Paul L Beck
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

7.  In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics.

Authors:  A W Chow; N Cheng; K H Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

8.  Survey of the extrachromosomal gene pool of Clostridium difficile.

Authors:  L L Muldrow; E R Archibold; O L Nunez-Montiel; R J Sheehy
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

Review 9.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Comparison of two toxins produced by Clostridium difficile.

Authors:  N S Taylor; G M Thorne; J G Bartlett
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.